Synokem Pharmaceuticals Limited Sustainability Profile
Synokem Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1988, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a diverse portfolio that includes formulations in therapeutic areas such as cardiology, neurology, and anti-infectives, Synokem is recognised for its commitment to innovation and quality. The company’s state-of-the-art manufacturing facilities adhere to stringent international standards, ensuring the delivery of safe and effective products. Synokem Pharmaceuticals has achieved significant milestones, including regulatory approvals from major global health authorities, solidifying its market position. With a focus on research and development, Synokem continues to expand its reach, contributing to improved healthcare outcomes worldwide.
DitchCarbon Score
How does Synokem Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Synokem Pharmaceuticals Limited's score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Synokem Pharmaceuticals Limited's reported carbon emissions
Synokem Pharmaceuticals Limited, headquartered in India, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Synokem Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Synokem to consider setting measurable targets and reporting their emissions to align with global climate goals.
How Carbon Intensive is Synokem Pharmaceuticals Limited's Industry?
How Carbon Intensive is Synokem Pharmaceuticals Limited's Location?
Synokem Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Synokem Pharmaceuticals Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
